AN IRISH research team has found a way to switch off a patient’s resistance to breast cancer treatments. The findings may also help spot women likely to develop resistance to the most often used therapies.
The research group at the Education and Research Centre at St Vincent’s University Hospital in Dublin is trying to develop a way to treat women with HER2-positive breast cancer. These patients, about one in five breast cancer cases, are resistant to treatment using Trastuzumab, better know as Herceptin, explained team leader Dr Patricia McGowan. (Times) >
Filed under: Cancer, Research Tagged: Breast cancer Image may be NSFW.
Clik here to view.
Image may be NSFW.Clik here to view.
